関連する実験動画
Updated: Feb 20, 2026
09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
27.9K
肥満はどのように定義されますか? 肥満の再定義のための現在の措置の限界を超越する
Adam Chang1, Andrew Cyr1, Spencer Weintraub2
1Zucker School of Medicine at Hofstra/Northwell, Department of Medicine, Northwell Health, Manhasset, New York, USA (Drs Chang, Cyr, and Rege).
Journal of clinical lipidology
|February 18, 2026
まとめ
肥満を定義するには,ボディマス指数 (BMI) を超えて,他の測定法を含める必要があります. このアプローチは,肥満に関連する疾患のリスクのある患者の早期発見を支援し,臨床管理を改善します.
科学分野:
- メタボリック疾患の研究
- 心血管の健康について
- 公共衛生上の課題は,公衆衛生上の課題である.
背景:
- 世界的な肥満の流行は,医療システムと患者にとって重大な課題を提示しています.
- 現在,肥満の定義のためにボディマス指数 (BMI) に依存しているため,重要な現象型の変動と心臓代謝リスクへの影響が無視されています.
研究 の 目的:
- 肥満を特徴づけるための現行および提案された方法をレビューする.
- 動脈硬化性心血管疾患と死亡率との強い関連を持つ診断アプローチを特定する.
- 肥満を定義し,臓器機能障害を特定するための枠組みを評価する.
主な方法:
- アントロポメトリック測定のレビュー.
- 炎症バイオマーカーの分析.
- 双重エネルギーX線吸収計 (DEXA) と磁気共鳴画像 (MRI) を用いて,内臓脂肪の評価.
- 心臓呼吸器のフィットネス対策を含める.
- 提案されている肥満の定義の枠組みの評価.
主要な成果:
- ボディマス指数 (BMI) だけでは,肥満とその関連リスクを特徴付けるには不十分です.
- DEXA,MRI,炎症バイオマーカー,心臓呼吸器フィットネスなどの方法は,より包括的な洞察を提供します.
- 提案された枠組みは,肥満に関連する臓器機能不全の早期かつより正確な識別を目的としています.
結論:
- BMIを超えて肥満の定義を再考することは,正確な診断と管理に不可欠です.
- 肥満の特徴の改善は,より良い患者層分化と介入戦略につながる可能性があります.
- 肥満の定義は,臨床実務,補償政策,患者の治療結果に影響を及ぼします.
さらに関連する動画
05:10Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.3K
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
14.8K
関連する概念動画
01:24Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
01:21Drug Dosing: Obese Patients
279
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
279
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
302
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
302
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
208
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
208
01:18Metabolic States of the Body: The Postabsorptive State
1.4K
The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
1.4K
01:02Hypodermis
7.9K
The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...
7.9K